Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOMARIN PHARMACEUTICAL INC Director's Dealing 2013

Feb 11, 2013

30583_dirs_2013-02-11_cf2e1ead-1466-450b-8771-4e5be3a9394c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2013-01-22

Reporting Person: MEIER RICHARD A (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-01-22 Common Stock M 5000 $16.92 Acquired 23650 Direct
2013-01-22 Common Stock S 5000 $55.00 Disposed 18650 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-01-22 Stock Option (right to buy) $16.92 M 5000 Disposed 2016-12-13 Common Stock (5000) Direct

Footnotes

F1: Transaction made pursuant to a Rule 10b5-1 Trading plan executed on December 11, 2012.

F2: Options vest 1/4th each on March 14, 2007, June 14, 2007, September 14, 2007 and December 14, 2007.